Medium-term real-world data for erenumab in 177 treatment resistant or difficult to treat chronic migraine patients: persistence and patient reported outcome measures after 17–30 m... von Troy, Emma, Shrukalla, Arif A., Buture, Alina, Conaty, Katie, Macken, Esther, Lonergan, Roisin, Melling, Jane, Long, Niamh, Shaikh, Eamonn, Birrane, Kieran, Tomkins, Esther M., Goadsby, Peter J., Ruttledge, Martin H.

Volltext

Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New... von Buture, Alina, Tomkins, Esther M., Shukralla, Arif, Troy, Emma, Conaty, Katie, Macken, Esther, Lonergan, Roisin, Melling, Jane, Long, Niamh, Birrane, Kieran, Shaikh, Eamonn, Goadsby, Peter J., Ruttledge, Martin H.

Volltext

Factors Associated With Burden of Primary Headache in a Specialty Clinic von Cassidy, Eugene M., Tomkins, Esther, Hardiman, Orla, O'Keane, Veronica

Volltext

Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone von Cassidy, Eugene M, Tomkins, Esther, Sharifi, Neda, Dinan, Timothy, Hardiman, Orla, O'Keane, Veronica

Volltext